Public Health
Five Interventions for Treating Multidrug-Resistant TB
The FDA has approved a drug combination that could be a game changer. We should make sure its use is equitable and sustainable
Stories by Ifeanyi Nsofor
Ifeanyi Nsofor is a medical doctor, CEO of EpiAFRIC and director of policy and advocacy at Nigeria Health Watch. He is a 2019 Atlantic Fellow for Health Equity at George Washington University and a Senior New Voices Fellow at the Aspen Institute. He has written opinion pieces for Inter Press Service, Project Syndicate, the Hill, Devex, African Arguments, AllAfrica and Vanguard. EpiAFRIC
